Equinox
Company

Last deal

$15M

Amount

Series B

Stage

31.03.2018

Date

1

all rounds

$15M

Total amount

General

About Company
Equinox is a medical technology company revolutionizing the treatment of glaucoma and other progressive eye diseases.

Industry

Sector :

Subsector :

Also Known As

Equinoxus

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Equinox, founded in 2014 and based in Newport Beach, California, is leveraging research and technology innovation to transform the treatment of glaucoma and other progressive eye diseases. Their non-pharmacological system adjusts intraocular pressure to match intracranial pressure, providing doctors with a deeper understanding of glaucoma based on the physics of eye pressure.